Natural killer lymphocytes: biology, development, and function

被引:96
作者
Papamichail, M [1 ]
Perez, SA [1 ]
Gritzapis, AD [1 ]
Baxevanis, CN [1 ]
机构
[1] St Savas Canc Hosp, Canc Immunol & Immunotherapy Ctr, Athens 11522, Greece
关键词
NK cells; NKT cells; receptors; cytokines; tumor models; stem cells; clinical trials;
D O I
10.1007/s00262-003-0478-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK) lymphocytes represent the first line of defense against virally infected cells and tumor cells. The role of NK cells in immune responses has been markedly explored, mainly due to the identification of NK cell receptors and their ligands, but also through the analysis of mechanisms underlying the effects of various cytokines on NK cell development and function. A population of lymphocytes that shares function and receptors with NK cells is represented by natural killer T (NKT) cells. NKT lymphocytes are regulators of both innate and adaptive immune responses, but have also been reported to function as effector antitumor cells. The marked progress in our understanding of the biology, development, and function of NK/NKT cells has provided the basis for their potential application in tumor clinical trials.
引用
收藏
页码:176 / 186
页数:11
相关论文
共 155 条
  • [1] Antitumor activity of interleukin-18 against the murine T-cell leukemia/lymphoma EL-4 in syngeneic mice
    Akamatsu, S
    Arai, N
    Hanaya, T
    Arai, S
    Tanimoto, T
    Fujii, M
    Kohno, K
    Micallef, MJ
    Ikeda, M
    Kurimoto, M
    [J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 : S28 - S34
  • [2] ARAMBURU J, 1990, J IMMUNOL, V144, P3238
  • [3] CYTOTOXICITY OF FRESH NK1.1(+) T-CELL RECEPTOR ALPHA/BETA(+) THYMOCYTES AGAINST A CD4+8+ THYMOCYTE POPULATION ASSOCIATED WITH INTACT FAS ANTIGEN EXPRESSION ON THE TARGET
    ARASE, H
    ARASE, N
    KOBAYASHI, Y
    NISHIMURA, Y
    YONEHARA, S
    ONOE, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) : 423 - 432
  • [4] NK1.1+ CD4+ CD8- THYMOCYTES WITH SPECIFIC LYMPHOKINE SECRETION
    ARASE, H
    ARASE, N
    NAKAGAWA, K
    GOOD, RA
    ONOE, K
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) : 307 - 310
  • [5] Targeting death and decoy receptors of the tumour-necrosis factor superfamily
    Ashkenazi, A
    [J]. NATURE REVIEWS CANCER, 2002, 2 (06) : 420 - 430
  • [6] Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
    Bauer, Stefan
    Groh, Veronika
    Wu, Jun
    Steinle, Alexander
    Phillips, Joseph H.
    Lanier, Lewis L.
    Spies, Thomas
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (07) : 2231 - 2233
  • [7] BAXEVANIS CN, 1995, CANCER, V76, P1253, DOI 10.1002/1097-0142(19951001)76:7<1253::AID-CNCR2820760724>3.0.CO
  • [8] 2-F
  • [9] In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18
    Baxevanis, CN
    Gritzapis, AD
    Papamichail, M
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (06) : 2953 - 2959
  • [10] Baxevanis CN, 2000, EUR J IMMUNOL, V30, P1957, DOI 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO